Medical Robotics Guide (2026)

Surgical robots ($1M-$4M) assist minimally invasive procedures. Rehabilitation robots ($100K-$500K) improve therapy consistency. Hospital logistics robots ($100K-$250K) automate supply and medication transport tasks that otherwise consume nursing time.

1) Clinical champion identified. 2) Case volume analysis completed. 3) Space requirements assessed. 4) IT infrastructure (WiFi, EMR integration) verified. 5) Training program budgeted (40-80 hrs per surgeon). 6) Regulatory compliance confirmed.

Ask about clinical evidence for your case mix, total 5-year cost, EMR integration, training/proctoring, uptime SLAs, peer references, technology roadmap, and HIPAA compliance.

Surgical robot systems range from $500,000 for single-specialty platforms to $2.5M+ for multi-specialty systems like the da Vinci 5. Annual service contracts add $150,000-$300,000. Per-procedure instrument costs run $700-$3,500. Most hospitals finance over 5-7 years.

Outcomes vary by procedure, surgeon experience, and patient factors. Robotic-assisted surgery is minimally invasive, which is generally associated with less blood loss and shorter recovery than open surgery — but specific outcome rates belong to the peer-reviewed literature for each procedure. Ask vendors for published clinical evidence for your specific case mix.

da Vinci (Intuitive) is a multi-specialty surgical platform for soft tissue procedures (prostatectomy, hysterectomy, cardiac). Mako (Stryker) specializes in orthopedic joint replacement with haptic boundary guidance. They serve different surgical specialties and are not direct competitors.

All medical robots used in the US require FDA clearance, typically through the 510(k) pathway. da Vinci, MAKO, Hugo RAS, and Ion are all FDA-cleared. Rehabilitation robots also require FDA classification. International markets require CE marking (EU), PMDA (Japan), or equivalent.

At 200+ robotic cases per year, most hospitals achieve payback in 3-5 years. Revenue drivers include attracting surgeons/patients, reducing complications, shorter OR times at scale, and premium reimbursement for certain procedures.